Algae biofuels: the wave of the future
Researchers at Virginia Bioinformatics Institute at Virginia Tech have assembled the draft genome of a marine algae sequence to aid scientists across the US in a project that aims to discover the best algae species for producing biodiesel fuel. The results have been published in Nature Communications.
The necessity of developing alternative, renewable fuel sources to prevent a potential energy crisis and alleviate greenhouse gas production has long been recognized. Various sources have been tried — corn for ethanol and soybeans for biodiesel, for example. But to truly meet the world's fuel needs, researchers must come up with a way to produce as much biofuel as possible in the smallest amount of space using the least amount of resources.
Enter algae. Unlike other crops like corn or soybeans, algae can use various water sources ranging from wastewater to brackish water and be grown in small, intensive plots on denuded land. While algae may still produce some C02 when burned, it can sequester C02 during growth in a way that fossil-fuel based energy sources obviously can't.
Scientists in VBI's Data Analysis Core (DAC), Robert Settlage, Ph.D., and Hongseok Tae, Ph.D., assisted in the assembly of the genome of Nannochloropis gaditana, a marine algae that may be capable of producing the lipid yields necessary for a viable fuel source.
"Getting the data is now the easy part. What we're doing in the DAC is enabling researchers to move beyond informatics issues of assembly and analysis to regain their focus on the biological implications of their research," said Settlage.
Further analysis revealed that with fairly straightforward genetic modification, N. gaditana should be capable of producing biofuel on an industrial scale, which may be the wave of the future in fuel research and production.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Artificial intelligence could improve therapy for lymphoma
Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
Yale Researchers Discover New Potential Asthma Therapeutic Targets Related to Parasites and Insects
Protagen Expands Cooperation with Bayer HealthCare
Emergent BioSolutions Announces Appointment of Ronald Richard to the Board of Directors

Deadly combination: new direct trigger for cell death discovered - Understanding the basic mechanisms that lead to cell death is essential for the development of therapies for cancer and other diseases

Bayer: Supervisory Board extends CEO Werner Baumann’s - Contract until the end of April 2024

Restoring vision by gene therapy - Latest scientific findings give hope for people with incurable retinal degeneration
Pantec Biosolutions receives ISO 13485 certification
Stora Enso awarded as Finland’s most startup-friendly company
Genetic screening before embryo transfer fails to improve the chance of a baby
